Advertisement

Neoleukin Therapeutics, Inc. NLTX

Set alert

Price alert · NLTX

All alert types
3.49 +3.49 —

Day range unavailable

52-week range unavailable

Open
—
Prev close
0.00
Mkt cap
8.20M
Vol
0
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
—
High
—
Forward P/E
-20.53
Beta
1.10
Short ratio
1.70
Inst. own
0.00%
Dividend
0.00
Ex-div date
Earnings
Nov 14, 2023
50-d avg
13.83
200-d avg
14.98
1y target
1.50

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for NLTX has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $5.43MIncome Tax Benefit → Expenses: $5.91MExpenses → Selling, General & Admin: $10.14MExpenses → Research & Development: $53.04MGross Profit → Expenses: $3.42MRevenue → Gross Profit: $3.42MRevenue → Cost of Revenue: $3.42MNet Loss → Expenses: $48.42MOther Income$5.43MIncome Tax Benefit$5.91MGross Profit$3.42MNet Loss$48.42MCost of Revenue$3.42MExpenses$63.18MSelling, General & Admin$10.14MResearch & Development$53.04MRevenue$6.84M

Period ending Jun 30, 2023 · select a line to chart its history

Income statement

NLTX quarterly income statement
3.07M
-426.00K
3.49M
-3.07M
-2.08M
-2.08M
-2.08M
-2.08M
-0.04
-0.04
-0.04
-2.08M
-2.08M
56.16M
56.16M

Balance sheet

NLTX quarterly balance sheet
31.11M
31.11M
50.95M
50.95M
83.78M
9.70M
94.00M
1.49M
11.04M
4.88M
9.55M
14.43M
-467.34M
-13.00K
79.58M
79.58M
10.22M
11.04M
9.55M
3.39M

Cash flow

NLTX quarterly cash flow
371.00K
-294.00K
-4.75M
1.98M
4.00K
-298.00K
-411.00K
-2.39M
-4.05M
331.00K
Advertisement